相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Baveno VII - Renewing consensus in portal hypertension
Roberto de Franchis et al.
JOURNAL OF HEPATOLOGY (2022)
Macrophage Activation Markers Predict Liver-Related Complications in Primary Biliary Cholangitis
Yukihisa Fujinaga et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Macrophage Activation Markers, Soluble CD163 and Mannose Receptor, in Liver Fibrosis
Rasmus Hvidbjerg Gantzel et al.
FRONTIERS IN MEDICINE (2021)
Circulating Macrophage Activation Markers Predict Transplant-Free Survival in Patients With Primary Sclerosing Cholangitis
Lars Bossen et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2021)
Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naive Patients With Primary Biliary Cholangitis: A Dual Cut-Off Approach
Laura Cristoferi et al.
HEPATOLOGY (2021)
Primary biliary cholangitis: pathogenesis and therapeutic opportunities
Aliya F. Gulamhusein et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis
Lars Bossen et al.
LIVER INTERNATIONAL (2020)
Macrophage markers and innate immunity in cirrhosis
Henning Gronbaek et al.
JOURNAL OF HEPATOLOGY (2020)
Soluble CD163 correlates with lipid metabolic adaptations in type 1 diabetes patients during ketoacidosis
Mads Svart et al.
JOURNAL OF DIABETES INVESTIGATION (2019)
Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases
Keith D. Lindor et al.
HEPATOLOGY (2019)
Diagnosis and Management of Primary Biliary Cholangitis
Zobair M. Younossi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)
Support of precision medicine through risk-stratification in autoimmune liver diseases - histology, scoring systems, and non-invasive markers
Lars Bossen et al.
AUTOIMMUNITY REVIEWS (2018)
Evolution of our understanding of PBC
Atsushi Tanaka et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2018)
Soluble CD163 and mannose receptor associate with chronic hepatitis B activity and fibrosis and decline with treatment
Tea Lund Laursen et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)
Rapid and persistent decline in soluble CD163 with successful direct-acting antiviral therapy and associations with chronic hepatitis C histology
Tea Lund Laursen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2018)
Macrophage activation marker sCD163 correlates with accelerated lipolysis following LPS exposure: a human-randomised clinical trial
Nikolaj Rittig et al.
ENDOCRINE CONNECTIONS (2018)
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score
Marco Carbone et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis
Gideon M. Hirschfield et al.
JOURNAL OF HEPATOLOGY (2017)
The soluble mannose receptor (sMR) is elevated in alcoholic liver disease and associated with disease severity, portal hypertension, and mortality in cirrhosis patients
Thomas Damgaard Sandahl et al.
PLOS ONE (2017)
Primary Biliary Cholangitis : Its Pathological Characteristics and Immunopathological Mechanisms
Koichi Tsuneyama et al.
JOURNAL OF MEDICAL INVESTIGATION (2017)
Single-centre experience of the macrophage activation marker soluble (s)CD163-associations with disease activity and treatment response in patients with autoimmune hepatitis
H. Gronbaek et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Toward precision medicine in primary biliary cholangitis
Marco Carbone et al.
DIGESTIVE AND LIVER DISEASE (2016)
Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF)
Henning Gronbaek et al.
JOURNAL OF HEPATOLOGY (2016)
Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery
Konstantin Kazankov et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
Primary biliary cirrhosis
Elizabeth J. Carey et al.
LANCET (2015)
The macrophage activation marker sCD163 is associated with changes in NAFLD and metabolic profile during lifestyle intervention in obese children
K. Kazankov et al.
PEDIATRIC OBESITY (2015)
Hepatic Macrophage Activation and the LPS Pathway in Patients With Alcoholic Hepatitis: A Prospective Cohort Study
Thomas Damgaard Sandahl et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Soluble CD163, a Macrophage Activation Marker, Is Independently Associated With Fibrosis in Patients With Chronic Viral Hepatitis B and C
Konstantin Kazankov et al.
HEPATOLOGY (2014)
Structural Basis for Inflammation-driven Shedding of CD163 Ectodomain and Tumor Necrosis Factor-α in Macrophages
Anders Etzerodt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
The Immunobiology and Pathophysiology of Primary Biliary Cirrhosis
Gideon M. Hirschfield et al.
Annual Review of Pathology-Mechanisms of Disease (2013)
Liver protective effect of ursodeoxycholic acid includes regulation of ADAM17 activity
Halka Buryova et al.
BMC GASTROENTEROLOGY (2013)
Soluble CD163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis
H. Gronbaek et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis
Christophe Corpechot et al.
HEPATOLOGY (2012)
Soluble CD163
Holger J. Moller
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2012)
Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: An overview of their mechanisms of action
Raoul Poupon
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2012)
Kupffer cells are activated in cirrhotic portal hypertension and not normalised by TIPS
Peter Holland-Fischer et al.
GUT (2011)
Biliary Apotopes and Anti-Mitochondrial Antibodies Activate Innate Immune Responses in Primary Biliary Cirrhosis
Ana Lleo et al.
HEPATOLOGY (2010)
Tumor necrosis factor α-converting enzyme (TACE/ADAM17) mediates ectodomain shedding of the scavenger receptor CD163
Anders Etzerodt et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
Ursodeoxycholic acid protects concanavalin A-induced mouse liver injury through inhibition of intrahepatic tumor necrosis factor-α and macrophage inflammatory protein-2 production
Kaoru Ishizaki et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Biological variation of soluble CD163
HJ Moller et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2003)
Tumor necrosis factor-α and transforming growth factor-β reflect severity of liver damage in primary biliary cirrhosis
M Neuman et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2002)
Characterization of an enzyme-linked immunosorbent assay for soluble CD163
HJ Moller et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2002)
Identification of the haemoglobin scavenger receptor
M Kristiansen et al.
NATURE (2001)
分享论文
